PATENT CLAIM ANALYSIS

Application Number: 16228310
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-05
Patent Classification: ["558", "070000"]

Abstract:
Cell binding agent-drug conjugates comprising phosphinate-based charged linkers and methods of using such linkers and conjugates are provided.

Claim (Index 3):
The compound of  claim 1 , wherein the cell-binding agent is an antibody, a single chain antibody, an antibody fragment that binds to the target cell, a monoclonal antibody, a single chain monoclonal antibody, or a monoclonal antibody fragment that binds the target cell, a chimeric antibody, a chimeric antibody fragment that binds to the target cell, a domain antibody, a domain antibody fragment that binds to the target cell, a resurfaced antibody, a resurfaced single chain antibody, or a resurfaced antibody fragment that binds to the target cell, a humanized antibody or a resurfaced antibody, a humanized single chain antibody, or a humanized antibody fragment that binds to the target cell, a lymphokine, a hormone, a vitamin, a growth factor, a colony stimulating factor, or a nutrient-transport molecule.

Metadata:
- Claim Count in Document: 19.0
- Percentile: 98.0
- Lexical Diversity: 1.1875
- Patent Class: 558.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15118726', '16228130', '16228437', '14432073', '12433604']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8280487195354348
- 35 USC 102 Novelty (BERT): 0.7094102459737768
- Combined Prediction Score: 0.816184872179269
- Mean Citation Score: 642.8125
- Max Citation Score: 727.0148
- Similarity Product: 705.0911031384945

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test